Holen Sie sich die Stockscreener-App
278.25
0.12%
0.16
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$278.09
Offen:
$279.02
24-Stunden-Volumen:
200.95K
Relative Volume:
0.14
Marktkapitalisierung:
$53.87B
Einnahmen:
$303.19B
Nettoeinkommen (Verlust:
$1.40B
KGV:
39.58
EPS:
7.03
Netto-Cashflow:
$-638.10M
1W Leistung:
+3.71%
1M Leistung:
+9.82%
6M Leistung:
+24.17%
1J Leistung:
+14.58%
1-Tages-Spanne:
$276.42
$280.00
1-Wochen-Bereich:
$267.90
$280.69
52-Wochen-Spanne:
$214.77
$280.69
Cencora Inc Stock (COR) Company Profile
Firmenname
Cencora Inc
Sektor
Branche
Telefon
610-727-7000
Adresse
1 WEST FIRST AVENUE, CONSHOHOCKEN
Vergleichen Sie COR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
278.28 | 53.87B | 303.19B | 1.40B | -638.10M | 7.03 |
|
MCK
Mckesson Corporation
|
671.82 | 84.34B | 344.58B | 2.83B | 1.63B | 21.84 |
|
CAH
Cardinal Health Inc
|
137.17 | 33.56B | 222.16B | 1.31B | -486.00M | 5.36 |
|
HSIC
Henry Schein Inc
|
69.29 | 8.50B | 12.50B | 314.00M | 421.00M | 2.44 |
|
PDCO
Patterson Companies Inc
|
31.25 | 2.75B | 6.55B | 155.22M | -823.13M | 1.71 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-09-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-31 | Eingeleitet | Citigroup | Buy |
| 2023-01-31 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-10-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-12 | Fortgesetzt | Evercore ISI | In-line |
| 2021-02-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-01-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Eingeleitet | Mizuho | Neutral |
| 2020-08-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Eingeleitet | Barclays | Underweight |
| 2020-06-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-04-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-02-11 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-07-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Eingeleitet | Guggenheim | Buy |
| 2019-04-10 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-10 | Herabstufung | Jefferies | Buy → Hold |
| 2018-10-26 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Eingeleitet | Berenberg | Buy |
| 2018-07-17 | Fortgesetzt | Stifel | Hold |
| 2018-04-09 | Eingeleitet | MoffettNathanson | Buy |
| 2018-03-12 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Eingeleitet | JP Morgan | Neutral |
| 2017-09-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Cencora Inc Aktie (COR) Neueste Nachrichten
Cencora to Announce Q2 Fiscal 2025 Results on May 7 - MSN
Cencora (COR) is a Top-Ranked Growth Stock: Should You Buy? - Yahoo Finance
Jim Cramer on Cencora (COR): “Smart Moves in the Drug Middleman Game!” - Insider Monkey
Zacks Industry Outlook Highlights Cencora, Doximity and Pediatrix Medical - Yahoo Finance
$290B Revenue Powerhouse Cencora Sets Critical Q2 Earnings Call Date - Stock Titan
Walden Group sale: DHL & Cencora show interest in deal - Trans.INFO
Cencora (COR) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
AmerisourceBergen stock soars to all-time high of $271.17 By Investing.com - Investing.com South Africa
Cencora executive chairman sells $3.9 million in stock By Investing.com - Investing.com Canada
Cencora EVP Elizabeth Campbell sells $1.1 million in stock By Investing.com - Investing.com South Africa
Cencora EVP Elizabeth Campbell sells $1.1 million in stock - Investing.com
Cencora executive chairman sells $3.9 million in stock - Investing.com
Deutsche Bank Adjusts Cencora Price Target to $285 From $24 - MarketScreener
AmerisourceBergen stock soars to all-time high of $271.17 - Investing.com
Walgreens Boots Alliance, Inc. Reduces Stake in Cencora Inc. - GuruFocus
Logistics Firm Walden Is Said to Draw Interest from DHL, Cencora - MSN
Insider Sell: Robert Mauch Sells Shares of Cencora Inc (COR) - GuruFocus
Walgreens Boots Alliance, Inc. (NASDAQ:WBA): Business Under Pressure as Legal Risks Mount - Yahoo Finance
Cencora CEO Robert Mauch sells $1.3 million in stock - Investing.com India
Cencora CEO Robert Mauch sells $1.3 million in stock By Investing.com - Investing.com South Africa
Here is Why Growth Investors Should Buy Cencora (COR) Now - Yahoo Finance
Cencora : EEO-1 Disclosure -March 17, 2025 at 09:42 am EDT - Marketscreener.com
Cencora, Inc. (COR): Among Top Insider Sales Last Month - Insider Monkey
What Analysts Are Saying About Cencora Stock - Benzinga
Wells Fargo Adjusts Price Target on Cencora to $274 From $251, Maintains Equalweight Rating - Marketscreener.com
CVS Health (CVS) Down 0.9% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Top 10 Insider Sales Last Month - Insider Monkey
SBI Securities Co. Ltd. Makes New Investment in Cencora, Inc. (NYSE:COR) - Defense World
Farminveste Says End Of Offer Period For Bond Loan 2025-2029 Changed To March 17 From March 14 - Marketscreener.com
Insider Sell: Silvana Battaglia Sells 5,000 Shares of Cencora In - GuruFocus.com
Is Cencora Stock Outperforming the Nasdaq? - MSN
Is Cencora Stock Outperforming The Nasdaq? - Barchart
Here's Why Cencora (COR) is a Strong Growth Stock - Yahoo Finance
Here's Why You Should Add Cencora Stock to Your Portfolio Now - MSN
Amundi Purchases 314,846 Shares of Cencora, Inc. (NYSE:COR) - MarketBeat
Cencora (NYSE:COR) Rating Increased to Buy at StockNews.com - Defense World
Cencora’s chief accounting officer sells $520,120 in stock By Investing.com - Investing.com Canada
Cencora’s chief accounting officer sells $520,120 in stock - Investing.com
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Cencora, Inc. (COR): Among Stocks With At Least $30 Million In Insider Sales Recently - Insider Monkey
Jones Financial Companies Lllp Has $537,000 Stock Holdings in Cencora, Inc. (NYSE:COR) - Defense World
Cencora, Inc. shareholders approve executive compensation, elect directors - Investing.com
Cencora, Inc. shareholders approve executive compensation, elect directors By Investing.com - Investing.com UK
AmerisourceBergen stock hits all-time high at $262.26 - Investing.com India
AmerisourceBergen stock hits all-time high at $262.26 By Investing.com - Investing.com South Africa
Cencora to Update 2025 Financial Guidance at Conference - TipRanks
CencoraAdjusted EPS For Fiscal 2025 Is Now Expected To Be In Range Of $15.30 To $15.60 - Marketscreener.com
Finanzdaten der Cencora Inc-Aktie (COR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.73%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):